NantHealth (NH) Stock Price
NantHealth Price
Revenue has compounded at 10.8% per year over the past 9 years to 67.00 M USD. NantHealth's net margin stands at -101.2%, up from -214.8% several years earlier. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.
NantHealth stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of NantHealth over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how NantHealth stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing NantHealth's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | NantHealth Price |
|---|
NantHealth Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
NantHealth Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e | 2026e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.00 | 33.00 | 46.00 | 80.00 | 86.00 | 89.00 | 77.00 | 73.00 | 62.00 | 67.00 | 83.00 | 110.00 | 126.00 | 138.00 |
| – | 26.92 | 39.39 | 73.91 | 7.50 | 3.49 | -13.48 | -5.19 | -15.07 | 8.06 | 23.88 | 32.53 | 14.55 | 9.52 |
| 30.77 | 27.27 | 54.35 | 45.00 | 52.33 | 50.56 | 55.84 | 58.90 | 54.84 | 56.72 | 56.72 | 56.72 | 56.72 | 56.72 |
| 8.00 | 9.00 | 25.00 | 36.00 | 45.00 | 45.00 | 43.00 | 43.00 | 34.00 | 38.00 | 47.07 | 62.39 | 71.46 | 78.27 |
| -41.00 | -60.00 | -44.00 | -120.00 | -67.00 | -50.00 | -30.00 | -25.00 | -40.00 | -51.00 | -39.00 | -25.00 | -31.00 | -39.00 |
| -157.69 | -181.82 | -95.65 | -150.00 | -77.91 | -56.18 | -38.96 | -34.25 | -64.52 | -76.12 | -46.99 | -22.73 | -24.60 | -28.26 |
| -40.00 | -84.00 | -88.00 | -189.00 | -175.00 | -192.00 | -62.00 | -56.00 | -58.00 | -67.00 | -33.00 | -21.00 | -26.00 | -34.00 |
| – | 110.00 | 4.76 | 114.77 | -7.41 | 9.71 | -67.71 | -9.68 | 3.57 | 15.52 | -50.75 | -36.36 | 23.81 | 30.77 |
| 120.73 | 120.73 | 88.97 | 111.60 | 116.74 | 109.17 | 110.35 | 7.40 | 7.61 | 7.70 | 7.70 | 7.70 | 7.70 | 7.70 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales NantHealth generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue NantHealth retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare NantHealth's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares NantHealth has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against NantHealth's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
NantHealth stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
NantHealth Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
NantHealth business model & stock analysis
NantHealth SWOT Analysis
Strengths
NantHealth Inc possesses several strengths that contribute to its success in the market. These include:
- Advanced healthcare technology solutions
- Strong intellectual property portfolio
- Robust network infrastructure
- Partnerships with leading healthcare organizations
- Strong financial position and stability
Weaknesses
Despite its strengths, NantHealth also faces certain weaknesses that can impact its performance. These weaknesses include:
- Dependence on a limited number of major clients
- Relatively high pricing of its solutions
- Integration challenges with existing healthcare systems
- Limited global market presence
- Perception of being a niche player in the market
Opportunities
NantHealth can capitalize on various opportunities to further expand its business. These opportunities include:
- Rising demand for digital healthcare solutions
- Increase in government initiatives promoting healthcare technology adoption
- Exploration of international markets
- Development of strategic partnerships with emerging startups
- Advancements in personalized medicine and genomics
Threats
NantHealth faces certain threats that could hinder its growth and success in the market. These threats include:
- Intense competition from established healthcare technology providers
- Rapidly changing regulatory landscape
- Data privacy and security concerns
- Potential healthcare system budget cuts
- Emergence of alternative technological solutions
NantHealth Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
NantHealth Segments
NantHealth Revenue by Segment
3 Years
5 Years
Max
Details
NantHealth Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
NantHealth historical P/E ratio, EBIT multiple, and P/S ratio
NantHealth annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
NantHealth shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
NantHealth stock splits
Current NantHealth forecasts and price targets in August 2026
Analyst Price Targets 2026NantHealth Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 11/17/2017 | Maintained | Buy | 65 | |
| 8/23/2017 | Maintained | Buy | 58 | |
| 8/21/2017 | Maintained | Buy | 65 | |
| 1/6/2017 | Maintained | Overweight | 41 | |
| 6/27/2016 | Maintained | Overweight | – | |
| 6/27/2016 | Maintained | Outperform | – | |
| 6/27/2016 | Maintained | Outperform | 60 | |
| 6/27/2016 | Maintained | Buy | 65 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
NantHealth Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 8/2/2023 | -0.07USD | - | 19.95 MUSD | - | 2023 Q2 |
| 5/3/2023 | -0.08USD | - | 18.39 MUSD | - | 2023 Q1 |
| 2/22/2023 | -0.08USD | - | 18.06 MUSD | - | 2022 Q4 |
| 11/3/2022 | -0.09USD | - | 17.53 MUSD | - | 2022 Q3 |
| 8/4/2022 | -0.09USD | - | 17.26 MUSD | - | 2022 Q2 |
| 5/5/2022 | -0.09USD | - | 16.67 MUSD | - | 2022 Q1 |
| 2/24/2022 | -0.09USD | - | 16.25 MUSD | - | 2021 Q4 |
| 11/4/2021 | -0.08USD | - | 17.26 MUSD | - | 2021 Q3 |
| 8/5/2021 | -0.10USD | - | 16.85 MUSD | - | 2021 Q2 |
| 5/6/2021 | -0.08USD | - | 18.60 MUSD | - | 2021 Q1 |
NantHealth shareholder structure
| % | Name |
|---|---|
0.12502% | |
0.05515% | |
0.02350% | |
0.01595% | |
0.00872% | |
0.00259% |
NantHealth Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
77.31% | SEC ↗ | |
62.84% | SEC ↗ | |
15.80% | SEC ↗ | |
15.80% | SEC ↗ | |
14.80% | SEC ↗ | |
14.70% | SEC ↗ | |
12.40% | SEC ↗ | |
0.41% | SEC ↗ | |
0.41% | SEC ↗ |
NantHealth Supply Chain
NantHealth Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | -0.86 | -0.82 | — | ||
| 2 | -0.87 | -0.88 | -0.77 |
Frequently asked questions about NantHealth
The business model of NantHealth Inc. revolves around providing innovative healthcare solutions through the integration of technology, data, and medical expertise. NantHealth Inc. develops and delivers a diverse range of products and services, including advanced molecular and genomic analysis, cloud-based software platforms, and clinical decision support tools. By leveraging their unique capabilities, NantHealth Inc. aims to empower healthcare providers and patients with the tools necessary for personalized and precision medicine. With a focus on improving patient outcomes and streamlining healthcare delivery, NantHealth Inc. strives to shape the future of healthcare through innovative solutions.
NantHealth Inc is primarily active in the healthcare industry.
The main competitors of NantHealth Inc in the market include MedPace Holdings Inc, Cerner Corporation, and Koninklijke Philips N.V.
NantHealth Inc. is a healthcare technology company established in 2010 by Dr. Patrick Soon-Shiong. With headquarters in California, it focuses on delivering innovative solutions to improve patient care and enhance clinical decision-making. NantHealth Inc. offers a wide range of personalized healthcare solutions, including advanced analytics, genomic sequencing, telehealth, and care coordination platforms. Leveraging cutting-edge technologies, the company aims to transform the healthcare industry by integrating data, diagnostics, and therapeutics. NantHealth Inc. has collaborated with leading healthcare organizations worldwide to provide comprehensive and precise healthcare solutions for patients. Through its innovative offerings, NantHealth Inc. strives to empower healthcare professionals and improve patient outcomes.
Some significant milestones achieved by NantHealth Inc include the successful completion of an IPO in 2016, securing partnerships with renowned healthcare providers and organizations, and the development and launch of innovative health technology solutions. The company has demonstrated remarkable progress in delivering advanced solutions that enable personalized and evidence-based medicine. Furthermore, NantHealth Inc's commitment to improving patient outcomes through the use of cutting-edge technology has garnered recognition and accolades within the industry. Prompted by their dedication to revolutionizing healthcare, NantHealth Inc has fostered numerous collaborations and achieved remarkable milestones in its pursuit of transforming medical practices.
NantHealth Inc is primarily present in the United States.
NantHealth Inc represents a strong commitment to revolutionizing the healthcare industry through innovative technologies and solutions. The company's corporate philosophy revolves around improving patient outcomes by providing personalized and data-driven healthcare options. NantHealth Inc focuses on leveraging advanced analytics, real-time data, and artificial intelligence to empower healthcare professionals with actionable insights. The company strongly believes in fostering collaboration among different stakeholders within the healthcare ecosystem to drive meaningful change and optimize patient care. NantHealth Inc aims to deliver cutting-edge solutions that enable healthcare providers to deliver efficient, cost-effective, and high-quality care to patients, ultimately leading to better health outcomes.
9 analysts currently rate the NantHealth stock: 8 recommend buying, 1 holding and 0 selling.
The NantHealth share (NH) is listed on 3 stock exchanges, including: NASDAQ (NH), Frankfurt (NEL.F), München (NEL.MU).
The company NantHealth Inc is a US-American company in the field of digital healthcare. It was founded in 2010 by Patrick Soon-Shiong, a successful entrepreneur in the biotechnology and oncology sector. NantHealth's business model is based on the development and marketing of IT solutions for the healthcare industry that help to improve the efficiency and quality of medical care. The company takes a holistic approach to healthcare and therefore offers various divisions. One of these divisions is the NantHealth Clinical Operating System (cOS), a platform for the digital networking of doctors, hospitals, and patients. This software is intended to optimize data exchange between the various actors in the healthcare sector, leading to better coordination of treatments and thus improved patient care. NantHealth also offers specialized solutions for cancer therapy. These include, among others, the GPS Cancer System, which is intended to enable precise diagnosis and treatment of cancer, as well as the Eviti Connect System, a platform for oncologists to access current study data and guidelines. Another offering from NantHealth is the home health solution called NaviNet. This is a platform that allows patients and their caregivers to communicate and coordinate the care process. This solution is particularly intended to help older and chronically ill patients stay in their familiar environment for longer while still receiving comprehensive medical care. NantHealth is also working on the development of artificial intelligence (AI) in healthcare. To this end, the company has founded NantAI, which is developing an AI platform for the analysis of images and clinical data. The goal is to enable faster and more accurate diagnosis as well as personalized therapy for patients. Overall, NantHealth's offerings aim to make healthcare more effective and efficient. Through the digitization and networking of the various actors in the healthcare sector, information should be made more quickly and easily accessible, which can lead to better diagnoses and treatments. The personalization of medical care also plays a major role in order to better consider individual needs and medical conditions. Overall, NantHealth is an innovative company that is at the forefront of the digital revolution in healthcare. With its diverse offerings and partnerships with other companies in the industry, NantHealth is committed to comprehensive digitization of the healthcare sector and thus contributes to the improvement of medical care.
The revenue cannot currently be calculated for NantHealth.
The profit cannot currently be calculated for NantHealth.
The P/E ratio cannot be calculated for NantHealth at the moment.
The P/S cannot be calculated for NantHealth currently.
The Eulerpool Quality Score for NantHealth is 2/10.
The ISIN of NantHealth is US6301041074. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of NantHealth is A2ALP8. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of NantHealth is NH. The ticker symbol is used to trade NantHealth shares on the stock exchange.
NantHealth is assigned to the 'Health' sector.
The dividends of NantHealth are distributed in USD.
NantHealth stock
NantHealth Peer Group
NantHealth Ticker
NantHealth FIGI
All fundamentals and in-depth analysis of NantHealth
Our stock analysis for NantHealth stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NantHealth. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.